Mice lacking both c-Jun-NH 2 -terminal kinases (JNK1 and JNK2) were generated to de®ne their roles in development. Jnk1/jnk2 double mutant fetuses die around embryonic day 11 (E11) and were found to display an open neural tube (exencephaly) at the hindbrain level with reduced apoptosis in the hindbrain neuroepithelium at E9.25. In contrast, a dramatic increase in cell death was observed one day later at E10.5 in both the hindbrain and forebrain regions. Moreover, about 25% of jnk12/2jnk21/2 fetuses display exencephaly probably due to reduced levels of JNK proteins, whereas jnk11/2jnk22/2 mice are viable. These results assign both pro-and anti-apoptotic functions to JNK1 and JNK2 in the development of the fetal brain. q
Introduction
Neural tube defects are major congenital anomalies of the central nervous system (CNS) with a combined frequency of 1 in 1000 live births (Edmonds and James, 1990) . These malformations are caused by various types of neural tube closure defects (Copp et al., 1990) . Current hypotheses suggest that the etiology of such defects is multifactorial, due to combined genetic and environmental factors (Campbell et al., 1986; Copp et al., 1990) . Neural tube formation is a dynamic process by which the lateral edges of the neural plate ®rst become elevated, subsequently bend towards each other, and then fuse along the dorsal midline to close the neural tube (Morriss-Kay, 1981; Campbell et al., 1986) . Neural tube closure involves cell migration, proliferation and apoptosis. Although many genetic loci were shown to be involved in this complex process, the underlying molecular events are not well de®ned (Harris and Juriloff, 1997) .
Various mitogenic and stress signals are transduced by conserved pathways that modulate expression of genes controlling cell proliferation, survival and death. These signals activate mitogen activated protein kinases (MAPKs) which regulate the activity of various transcription factors (Cobb and Goldsmith, 1995; Karin and Hunter, 1995) . Several MAPK subgroups that differ in their response and substrate speci®cities, including ERKs, JNKs and p38s (the latter two are also known as stress activated protein kinases or SAPKs) were described. All MAPKs are regulated by three-member protein kinase cascades composed of MAPK, MAPK kinase (MAPKK) and MAPKK kinase (MAPKKK). Unlike the ERKs, which are activated most effectively by growth factors and mitogens (Cobb and Goldsmith, 1995; Marshall, 1995) , the JNK and p38 cascades are activated by proin¯ammatory and stress stimuli (Minden and Karin, 1997) . Activated JNKs phosphorylate transcription factors such as c-Jun and ATF-2, which participate in the formation of the AP-1 complex and target gene induction (Karin, 1996) . The JNKs are activated by JNKK1 (SEK1, MKK4) and JNKK2 (SEK2, MKK7) Sanchez et al., 1994; Lin et al., 1995; Tournier et al., 1997; Wu et al., 1997) , which are responsive to numerous MAPKKKs (Fanger et al., 1997) . The JNK subgroup consists of three members: JNK1, JNK2 and JNK3 Kallunki et al., 1994; Mohit et al., 1995) , each with multiple isoforms generated through alternate splicing (Gupta et al., 1996) . Different JNK isoforms differ in their af®nity to substrates such as c-Jun, suggesting that they may have both distinct and overlapping functions (Kallunki et al., 1994 (Kallunki et al., , 1996 . Combinatorial use of various JNKs, JNKKs and MAPKKKs can lead to JNK activation in response to multiple stimuli and differential regulation of downstream targets.
The JNKs are believed to be involved in controlling cell proliferation and oncogenic transformation through their effects on AP-1 (Minden and Karin, 1997) . However more recently, JNK activation was suggested to induce programmed cell death. Despite their implications in such diverse and essential cellular functions, mutant mice lacking individual jnk genes are viable, indicating that they might have redundant or overlapping functions during embryonic development (Yang et al., 1997a; Dong et al., 1998; Sabapathy et al., 1999) . The absence of JNK3 results in increased resistance to stress-induced neuronal apoptosis in adult mice (Yang et al., 1997a) , suggesting that this gene product has speci®cally evolved to transduce stress signals in neurons. JNK activation may also be responsible for neuronal cell death caused by removal of survival factors (Le-Niculescu et al., 1999) .
To determine the combined roles of JNK1 and JNK2 in these processes, mice lacking both loci were generated. Jnk1/jnk2 double mutants (i.e. jnk12/2jnk22/2) are embryonic lethal and exhibit failure of neural tube closure. This defect is likely due to region and developmental stagespeci®c alterations in apoptosis in the unfused neural folds of the developing brain. Speci®cally, decreased apoptosis was observed in the hindbrain of E9.25 double mutants. However at E10.5, the double mutants exhibited increased apoptosis in both the hindbrain and forebrain neuroepithelium. Recently, Kuan et al. (1999) reported similar ®ndings except that increased apoptosis was observed only in the forebrain of E10.5 and E11.5 double mutant embryos, but not in the hindbrain. Furthermore, we show that loss of both jnk1 alleles and one jnk2 allele results in an exencephalic phenotype, suggesting that JNK gene dosage might be critical in regulating neural tube closure. Together, these results suggest both pro-and anti-apoptotic roles for JNK1 and JNK2 during neural tube morphogenesis, which are different from the speci®c pro-apoptotic role of JNK3 in response to stress in mature neurons.
Results

Lack of both jnk1 and jnk2 results in embryonic lethality
JNK1 and JNK2 are ubiquitously expressed in the mouse whereas JNK3 is brain-speci®c (Mohit et al., 1995; Kuan et al., 1999) . As JNK1 and JNK2 are also expressed at high levels in the brain (Fig. 1a,b) , we investigated if they play essential roles in nervous system development and function by generating jnk1/jnk2 double mutants. Jnk11/2jnk22/2 mice were intercrossed to obtain double mutants. Among 61 offspring obtained at weaning age, no double mutants were found, indicating that the jnk1/jnk2 mutation is recessive lethal (Table 1) . We therefore examined the morphological phenotype of mutant fetuses at different stages of gestation. No live double mutant fetuses were found between E14.5 and E15.5 (Table 1) . At E12.5, a time point around which cjun mutant fetuses die (Hilberg et al., 1993) , four of 20 fetuses were identi®ed as double mutants, but all were resorbed (Table 1) . At E11.5, six of 27 fetuses were double mutants, and all were just dead as determined by lack of heart beating. These fetuses were also growth retarded and exhibited neural tube closure defects. Between E9.25 and E10.5, 13 of 45 fetuses were double mutants, and although all were alive, they displayed defective neural tube closure (Fig. 2) . Therefore, lack of both JNK1 and JNK2 results in embryonic lethality around E11.
Defective neural tube morphogenesis in jnk1/jnk2 mutants
The most conspicuous feature of E10.5 jnk1/jnk2 double mutants is a severe malformation of the brain resulting from failed closure of the neural folds at the hindbrain region (Fig. 2b) . In the mouse, neural tube closure is initiated at the cervical/hindbrain boundary (Morriss-Kay et al., 1994) . Two additional closure sites occur at the caudal and rostral limits of the forebrain (Juriloff et al., 1991) . Closure then spreads along the neural folds in the rostral and caudal directions. In the mutants, the neural folds were elevated but their lateral edges did not bend medially to fuse (Fig.  2d) . The closure defect in jnk1/jnk2 double mutants involved the midbrain/hindbrain boundary and extended caudally to the cervical/hindbrain boundary, whereas the forebrain and spinal neural folds were closed (Fig. 2b) . Histological analysis revealed thickening and eversion of the neuroepithelium at the level of the fourth ventricle (Fig. 2d) . The lumen of the forebrain vesicles was incompletely formed. This could be secondary to incomplete hindbrain closure or due to a defect in the neuroepithelial lining. However, the thickness of the forebrain neuroepithelium and the density of mesenchymal cells underlying the head region were comparable in double mutant and control fetuses and showed no obvious histological defects (Fig.  2c,d ).
Jnk12/2jnk21/2 fetuses exhibit exencephaly
We also tested whether the loss of three out of four jnk alleles affects embryonic development. Out of 109 offspring obtained at weaning age by crossing jnk11/2jnk21/1 with jnk11/2jnk22/2 mice, only 17 were jnk12/2jnk21/2, which is considerably lower than the expected Mendelian ratio of 25% (Table 1) . This suggested that some jnk12/2jnk21/2 fetuses were lost during embryogenesis. Therefore, subsequent analysis was performed between E13.5 and E15.5. Of 62 fetuses, 14 were jnk12/2 jnk21/2, and of these, four exhibited exencephaly (Fig. 3b) . Moreover, by crossing jnk12/2jnk21/1 with jnk11/2jnk22/2 mice, we recovered nine out of 20 fetuses between E12.5 and E15.5 that were jnk12/2jnk21/2 (Table 1) , which is within the expected range of 50%. Of these, two fetuses also exhibited exencephaly (Table 1 ). Therefore, some fetuses which completely lack JNK1 and have only one jnk2 allele display defects in brain morphogenesis, similar to the jnk1/ jnk2 double mutant phenotype. By contrast, mice that completely lack JNK2 and have only one jnk1 allele were obtained in Mendelian ratio and did not display overt developmental abnormalities (data not shown). Moreover, the observed exencephalic phenotype is speci®c to both jnk12/2jnk22/2 and jnk12/2jnk21/2 mutants, as over 100 jnk12/2, jnk22/2 and wild-type embryos of the pure 129/Sv and the mixed BL6/129/Sv backgrounds analyzed did not show this phenotype.
As jnk12/2jnk21/2 fetuses survived past E11, we analyzed the exencephalic phenotype at later stages of development. At E12.5 the neural tube remained open over the complete antero-dorsal extent of the brain in exencephalic jnk12/2jnk21/2 fetuses (Fig. 3b) . The cranial roof was completely missing in the exencephalic mutants ( Fig. 3d,f) . Histological examination revealed prominent and ubiquitous disturbance of the normal brain architecture indicated by abnormal folding of the neuroepithelium and obliteration of the cerebral ventricles (Fig. 3d ,f,h). However, differentiation of the neuroepithelium seemed to occur normally (Fig. 3h) . By E15.5, there was prominent upward expansion and protrusion of brain tissue accompanied by enlargement of the diencephalon and lateral displacement of the cerebral hemispheres (Fig. 3f) . By contrast, no overt abnormalities of the trigeminal ganglia, the retina, the spinal cord, dorsal root ganglia and other non-neuronal organs were detected in exencephalic fetuses (data not shown). Thus, the neural tube closure defect, initially observed at E10.5 in jnk12/2jnk22/2 fetuses, could dramatically affect brain morphogenesis later in development, as manifested in the jnk12/2jnk21/2 mutants.
As only jnk12/2jnk21/2 fetuses exhibited exencephaly, the levels of JNK proteins were analyzed in brain extracts of jnk12/2jnk21/2 and various control mice and fetuses using an antibody that detects both long and short JNK1 and JNK2 isoforms. At least one long and one short JNK1 isoform and one long and two short JNK2 isoforms were detected in wild-type brain extracts ( Fig.  1b ; lanes 1±3). The long JNK1 isoform was expressed at lower levels than the long JNK2 isoform and the short JNK1 ) a Mice were weaned and genotyped at three weeks of age. All mice were on a mixed BL6/129/Sv background. Results are indicated from jnk11/2jnk22/2 intercrosses (a) and from breeding either jnk11/2jnk21/1 £ jnk11/2jnk22/2 (b) or jnk12/2jnk21/1 £ jnk11/2jnk22/2 (c) mice. From the intercrosses in (a), jnk12/2jnk22/2 mutants can be expected. From the crosses in (b) and (c), jnk12/2jnk21/2 or jnk11/2jnk22/2 mutants are expected. Of these, only the jnk12/2jnk21/2 mutants exhibited exencephaly. isoform was expressed at higher levels than the short JNK2 isoforms, as seen in extracts from jnk1 and jnk2 mutant brains ( Fig. 1b; lanes 2 and 3) . Both the long and short isoforms of JNK2 were expressed at extremely low levels in jnk12/2jnk21/2 brain extracts from both normal and exencephalic fetuses, compared to jnk12/2jnk21/1 brain extracts (Fig. 1b , lane 5 compared to lane 2). However, although the levels of JNK1 protein were reduced in jnk11/2jnk22/2 brain extracts compared to the jnk11/1jnk22/2 counterparts ( Fig. 1b ; lane 6 compared to lane 3), the total amount of JNK protein was lowest in the jnk12/2jnk21/2 brain extracts, as considerable amounts of JNK2 isoforms were also detected in jnk12/2jnk21/1 and jnk11/2jnk21/2 brain extracts ( Fig. 1b ; lanes 2 and 4). The low relative expression of JNK2 is speci®c to the brain, as spleen extracts from jnk12/2jnk21/2 mice contained considerable amounts of JNK2, comparable to those expressed by spleens of other genotypes ( Fig. 1c ; lanes 1±5). JNK isoform expression in embryonic ®bro-blasts established from mice of the different genotypes was similar in pattern and relative levels to that in spleen extracts (data not shown). Thus, the markedly reduced expression of total JNK proteins in the brain correlates with the presence of the exencephalic phenotype in some jnk12/2jnk21/2 fetuses.
Apoptosis and proliferation in mutant fetuses
Neural tube formation requires coordinate shaping, bending and eventually closure of the neural plate (Sakai, 1989; Schoenwolf and Smith, 1990) . Proliferation and apoptosis of the neuroepithelium contribute at least partially to these processes (McKay et al., 1994) . To determine whether impairment of neural tube closure might be caused by abnormal cell death or proliferation, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assays and BrdU immunohistochemistry to measure cell proliferation were performed on E9.25 fetuses, a time point just prior to neural tube closure, and on E10.5 fetuses, a time point at which jnk12/2jnk22/2 fetuses exhibit an open neural tube. Control E9.25 fetuses contained a high proportion of apoptotic cells in the hindbrain region, concentrated mostly at the edges of the folding neural tube (Fig. 4a) . However, only a few TUNEL-positive cells were found in this region in the jnk12/2jnk22/2 mutants (Fig.  4b) , indicating that loss of both JNK1 and JNK2 results in reduced apoptosis at this developmental stage. The difference was speci®cally observed in the hindbrain, as the numbers of apoptotic cells present in the forebrain neuroepithelium were comparable between jnk12/2jnk22/2 mutants and control fetuses (data not shown). In striking contrast to E9.25 jnk12/2jnk22/2 mutants, there was a large increase in the number of apoptotic cells in the hindbrain neuroepithelium of E10.5 jnk12/2jnk22/2 mutants, in comparison to the small number of TUNEL-positive cells in the same region of E10.5 control fetuses (Fig. 4 c,d ). This result is in contrast to those of Kuan et al. (1999) who described normal levels of apoptosis in the hindbrain neuroepithelium of E10.5 double mutant fetuses. The unfused tips of the neural folds in jnk1/jnk2 mutants also contained apoptotic cells (data not shown), indicating that JNK1 and JNK2 transduce both pro-and anti-apoptotic signals in a developmental stage-and region-speci®c manner. Interestingly, the increase in apoptosis in E10.5 jnk12/2jnk22/2 mutants was not restricted to the hindbrain region, as increased apoptosis was observed in the forebrain neuroepithelium, especially in the lamina terminalis, the optic stalk and the trigeminal ganglia ( Fig.  4e,f; data not shown). However, both jnk1/jnk2 double mutant and control fetuses showed only a few TUNEL-positive cells in the cranial mesenchyme (data not shown). In addition, analysis of E12.5 and E15.5 exencephalic jnk12/2jnk21/2 fetuses revealed no signi®cant differences in the number of apoptotic cells between them and control fetuses in the periventricular neuroepithelium of the telencephalon, the retina, the trigeminal ganglia and the spinal cord (Fig. 3k,l) . In addition, brain extracts from jnk12/2jnk21/2 exencephalic embryos had comparable levels of caspase-3 activity as determined by an in vitro caspase-3 activity assay (data not shown). This suggests that increased apoptosis observed in E10.5 jnk12/2jnk22/2 mutant neuroepithelium might not be a secondary effect of extended exposure to the amniotic environment, but might be causally related to the absence of JNK1 and JNK2.
At E9.25 and E10.5, jnk1/jnk2 double mutant and control fetuses showed comparable numbers of BrdU-positive cells in the neuroepithelium of the hind-and forebrain (data not shown). Furthermore, there was also no difference in the number of BrdU-positive cells in the head mesenchyme between jnk1/jnk2 double mutant and control fetuses (data not shown), thereby excluding impaired proliferation as a cause for defective neural tube closure. In addition, analysis of exencephalic E12.5 and E15.5 jnk12/2jnk21/2 fetuses, which had protruding brain tissue, revealed no signi®cant increase in the number of BrdU-positive cells in the neuroepithelium of the forebrain, the retina, trigeminal ganglia and spinal cord compared to control fetuses ( Fig. 3i,j; data not shown).
We also analyzed potential substrates of the JNKs that may be involved in brain morphogenesis. Western blot analysis of brain extracts from jnk12/2jnk21/2 and control fetuses revealed that expression of c-Jun and its basal phosphorylation status were not altered in the mutants (data not shown), suggesting that c-Jun and its phosphorylation by the JNKs is not essential for neural tube closure. We also examined the expression of Pax-3 and p53 which were shown to be essential for cranial neural tube closure (Epstein et al., 1991) , and did not ®nd any signi®cant difference between fetuses of the different genotypes (data not shown).
Discussion
The results presented here provide strong genetic evidence that expression of both JNK1 and JNK2 is required for proper neural tube morphogenesis. JNK1 and JNK2 have important roles in controlling apoptosis in the developing brain, as their absence results in deregulated developmental apoptosis leading to the neural tube defects observed in jnk12/2jnk22/2 fetuses. Our results identify both proand anti-apoptotic functions for JNK1 and JNK2, which are distinct from the speci®c pro-apoptotic role of JNK3 in mature neurons exposed to excitotoxins.
An open neural tube is a phenotypic feature of several other mice with targeted disruption of genes encoding for transcription factors and cofactors that regulate gene expression, or proteins that are part of the apoptotic machinery. However, to our knowledge, besides JNK MAP kinases no other component of a commonly used signaling pathway has been implicated in cranial morphogenesis. Disruption of the jnkk1(sek1) gene does not result in neural tube defects (Yang et al., 1997a) . In addition, mek-12/2, mkk-32/2, p38-a 2/2, ikk-a 2/2 and ikk-b 2/2 mutants do not exhibit neural tube defects (Yang et al., 1997b; Giroux et al., 1999; Hu et al., 1999; Li et al., 1999) (Tamura, K. and MK, unpublished data) . Moreover, single jnk mutants also do not show this defect. Thus, the requirement for loss of both jnk1 and jnk2 to cause neural tube closure defects indicates an intricate mechanism that precisely regulates developmental signals. It is possible that both JNK1 and JNK2 either phosphorylate a common target essential for proper neural tube morphogenesis or that they act in parallel to phosphorylate multiple targets that regulate cell death during this process.
Recently, we generated mice in which the JNK phosphoacceptor sites of c-Jun are replaced with alanines, thus rendering c-Jun unphosphorylable by the JNKs. These mutant mice are viable and do not show any developmental cranial defects, although they are resistant to kainic acid induced epileptic seizures and apoptosis, thus phenocopying the JNK3 de®cient mice (Behrens et al., 1999) . Unlike these mice, surviving jnk12/2jnk21/2 mice are not more resistant to epileptic seizures induced by kainic acid treatment . Model for distinct biological functions of various JNKs in the nervous system. Proposed roles of JNK1 and JNK2 vs. JNK3 in the nervous system. During CNS development, JNK1 and JNK2 are essential in regulating programmed cell death in a stage-and region-speci®c manner. In the absence of JNK1 and JNK2, there is an initial decrease in apoptosis in the hindbrain neuroepithelium of the closing neural tube (E9.25) followed by an increase in apoptosis at E10.5 in both fore-and hindbrain, eventually resulting in failure of neural tube closure. By contrast, JNK3 mediates proapoptotic signals during excitotoxin-induced stress in mature neurons. Black dots represent apoptotic cells.
(data not shown). Therefore, JNK1 and JNK2 do not appear to be involved in excitotoxic apoptosis in mature neurons. The absence of JNK1 and JNK2 also has no effect on expression of c-Jun or its basal N-terminal phosphorylation in the CNS. Thus, c-Jun is unlikely to be involved in neural tube closure or other aspects of CNS morphogenesis. These results suggest that in the CNS, JNK3 phosphorylates c-Jun, while JNK1 and JNK2 must have other targets. Moreover, cjun de®cient fetuses, which survive up to E12.5, do not show defects in cranial morphogenesis (Hilberg et al., 1993; Eferl et al., 1999) . We also generated conditional c-jun mouse mutants in which c-jun was deleted in nestin-expressing neurons by Cre-recombinase activity. These mice do not show any cranial morphogenetic defects (A. Behrens and EFW, unpublished data) . Together, these data argue strongly against c-Jun being a critical target for JNK1 and JNK2 in the control of CNS morphogenesis. Mutants lacking other JNK substrates were also generated, including ATF-2 and ATF-a. These mutants are viable and do not show developmental cranial defects (Reimold et al., 1996; W. Breitwiesser and N. Jones, personal communication) . It is therefore possible that JNK1 and JNK2 are required in combination to phosphorylate multiple targets, which are then required for proper neural tube morphogenesis. This would add another level of control over the substrates, thus increasing the complexity of the signaling cascade.
Apoptosis is an important feature of nervous system morphogenesis. Mouse mutants which exhibit similar defects in cranial morphogenesis can be classi®ed into at least two categories based on alterations in apoptosis: AP-22/2, cart-12/2 and ski2/2 fetuses exhibit increased apoptosis between E8.75 and E10.5 (Schorle et al., 1996; Zhao et al., 1996; Berk et al., 1997) , whereas caspase-32/2, caspase-92/2 and Apaf-12/2 fetuses exhibit decreased apoptosis between E12.5 and E16.5 (Kuida et al., 1996 (Kuida et al., , 1998 Cecconi et al., 1998; Hakem et al., 1998; Yoshida et al., 1998) . Apoptosis at earlier stages (between E8.5 and E10) was not determined in the latter mutant fetuses. However, jnk12/2jnk22/2 mutants display decreased apoptosis in the brain at E9.25 and increased apoptosis at E10.5. These data demonstrate that the same signaling molecules are used to transduce or modulate both cell survival and death signals during early brain development. Moreover, apoptosis is regulated in a region-speci®c manner. At E9.25, JNK1 and JNK2 positively regulate apoptosis in the hindbrain region, whereas at E10.5 they negatively regulate apoptosis in both the hindbrain and forebrain regions. Recently, Kuan et al. (1999) reported that E9.0 jnk12/2jnk22/2 fetuses displayed decreased apoptosis in the hindbrain region and that there was an increase in apoptosis in E10.5 double mutant fetuses, but only in the forebrain region. The authors claimed that no differences in apoptosis were observed in the hindbrain regions of E10.5 jnk12/2jnk22/2 fetuses (Kuan et al., 1999) . This discrepancy is probably due to a different method used to detect cell death. The former analysis was done by Toluidine blue staining of semi-thin sections, in which the number of blue cells was correlated to the frequency of apoptotic cells. However, this method is probably less sensitive than the TUNEL reaction, which was used in our study. An alternative explanation resides in the interpretation of the data presented. Although the authors claim that there is no increase in apoptosis in the hindbrain neuroepithelium of double mutant fetuses compared to controls at E11.5, increased numbers of blue cells are apparent in the hindbrain region ( Figure 5J of Kuan et al., 1999) . Based on our results, we conclude that increased apoptosis is not restricted to the forebrain, but also occurs at the hindbrain region of the jnk12/2jnk22/2 E10.5 mutants. Nonetheless, all data indicate that the defect in neural tube closure is due to deregulated apoptosis, although causal role of JNKs in regulating cell migration cannot be excluded.
Although increased apoptosis was observed in the developing brain of E10.5 jnk12/2jnk22/2 fetuses, there were no alterations in cell death in the exencephalic E12.5 or E15.5 jnk12/2jnk21/2 mutants. This suggests that the increase in apoptosis is not a secondary effect due to extended exposure to the amniotic environment, but causally related to the absence of both JNK1 and JNK2. Nevertheless, we cannot exclude the possibility that the increased apoptosis at E10.5 was a transient secondary effect since the increase was not detectable in jnk12/2jnk21/2 fetuses at E12.5 and E15.5.
Gene dosage appears to play a critical role in controlling JNK protein levels in the brain. The total amount of JNK proteins were barely detectable in normal and exencephalic jnk12/2jnk21/2 brain extracts. By contrast, jnk11/2jnk22/2 brain extracts contained considerable amounts of total JNK proteins. Moreover, jnk12/2jnk21/2 spleens and embryonic ®broblasts contained higher levels of JNK proteins than brain extracts of the same mice, indicating that the reduction in total JNK expression is probably speci®c to brains of jnk12/2jnk21/2 mice. Thus, it appears that a certain level of JNK expression is essential for proper neural tube closure. Below this level, exencephaly is manifested. However, the possibility that reduced levels of total JNK protein in jnk12/2jnk21/2 brain extracts are a consequence of the exencephalic phenotype cannot be excluded. Nevertheless, only about 25% of jnk12/2jnk21/2 fetuses develop exencephaly, indicating partial penetrance. The jnk12/2jnk21/2 mice used in this study were of a mixed BL6/129/Sv genetic background and hence, not genetically identical. As the exencephalic phenotype is strongly dependent on multiple genetic factors, it is possible that the phenotype would be more penetrant in an inbred background.
The observed protrusion of brain tissue in exencephalic jnk12/2jnk21/2 mutants is likely a result of failed neural tube closure. As the neural tube remains open, it could be envisaged that a proper size control mechanism is disturbed. As no differences in cell proliferation were detected in the neuroepithelium and mesenchyme of these mutants, it is possible that proper patterning and folding did not occur in the jnk12/2jnk21/2 exencephalic mutants, thus leading to displacement of the brain tissue through the open neural tube. This is reminiscent of ski2/2 mutants, which also do not show any increase in proliferation (Berk et al., 1997) .
As mutants de®cient in individual JNK loci are viable and do not show any obvious developmental defects (Yang et al., 1997a; Dong et al., 1998; Sabapathy et al., 1999) , these genes might play redundant roles during embryogenesis. However, the loss of both JNK1 and JNK2 leads to embryonic lethality around E11. The neural tube defect, however, cannot be the cause of lethality as jnk12/2jnk21/2 fetuses with exencephaly could survive up to E16. Thus, the lack of both JNK1 and JNK2 probably affects other functions essential for embryonic survival.
In summary, the results presented here demonstrate that JNK1 and JNK2 regulate apoptosis in a spatial and temporal manner, thus transducing both pro-and anti-apoptotic signals which shape the developing brain. This is in contrast to the proposed speci®c pro-apoptotic role of JNK3, which transmits stress signals in mature neurons (Fig. 5) . In addition, c-Jun is not the critical target of JNK1 and JNK2 in the developing brain, whereas it is the essential target for JNK3 in mature neurons. These results suggest distinct biological functions of various JNK isozymes in the nervous system with JNK3 being involved in excitotoxicity-induced apoptosis and JNK1 and JNK2 variably regulating developmental programmed cell death during CNS development.
Experimental procedures
Analysis of fetuses
Jnk22/2 mice were described in Sabapathy et al. (1999) . Using a similar strategy, we have generated jnk12/2 mice that are viable and exhibit no major anomalies (our unpublished data). Brie¯y, BL6/129/Sv chimeras were crossed with either BL6 or 129/Sv wild-type mice to obtain heterozygotes, which were intercrossed to get homozygous mutant mice. These jnk12/2 mice were crossed to jnk22/2 mice to get double heterozygotes which were then used to generate the double mutant mice. These mice are hence of a mixed BL6/129/Sv background. We have not observed any exencephalic wild-type fetuses from over 100 analyzed. Moreover, both jnk12/2 and jnk22/2 fetuses in both the pure 129/Sv or mixed BL6/129/Sv backgrounds did not display the exencephalic phenotype. Jnk1 and jnk2 mutant mice on a BL6/129/Sv background were intercrossed to generate jnk12/2jnk22/2 mutants and fetuses of other allelic combinations. Fetuses were isolated between E9.25 and E16.5 post-coitum for analysis.
Histological analysis, BrdU immunohistochemistry and TUNEL assay
Pregnant females were injected intraperitonially with 100 mg of bromodeoxyuridine (BrdU) per g of body weight 1 h prior to sacri®ce for analysis of cell proliferation. Embryos were ®xed in 4% formaldehyde, dehydrated, embedded in paraf®n and sectioned (5 mm). For histological analysis sections were stained with Harris haematoxylin and eosin (H&E; Sigma). For BrdU immunohistochemistry sections pretreated with protease type XXIV and 2 M HCl were incubated with biotinylated mouse monoclonal anti-BrdU antibody (Caltac; 1:50 dilution) at 48C overnight. The signal was ampli®ed with the Vectastain ABC Kit (Vector Laboratories) and visualized with 3,3
H -diaminobenzidine (Vector Laboratories). Sections were counterstained with Harris haematoxylin (Sigma). For detection of apoptotic cells histological sections prepared as above were rehydrated, pretreated with proteinase K (20 mg/ml) and incubated with TUNEL assay mix (Boehringer Mannheim) prepared according to the manufacturer's instructions. Samples were then counterstained with propidium iodide (1 mg/ml).
Western blot analysis
Brain tissues of control and exencephalic fetuses and adult brains and spleens of various genotypes were minced in phosphate-buffered saline (PBS) to obtain single cell suspensions. The cells were then pelleted and extracts were prepared as described (Sabapathy et al., 1999) . Between 50 and 250 mg of cell extracts were used for Western blot analysis according to standard procedures (Sabapathy et al., 1999) . Brie¯y, the extracts were separated on sodium dodecyl sulphate (SDS)-polyacrylamide gels, transferred onto Immobilon-P membrane (Millipore) and probed with anti-JNK1/JNK2 (666.8) (Pharmingen) and actin (Sigma) antibodies.
